Published in Ann Surg Oncol on June 01, 1997
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg (2007) 4.73
Remnant uptake as a postoperative oncologic quality indicator. Thyroid (2013) 1.56
Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg (2011) 1.49
Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg (2014) 1.26
New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin (2013) 1.16
TNM classification of thyroid carcinoma. World J Surg (2007) 1.10
Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol (2004) 0.95
Exploiting biology in selecting treatment for differentiated cancer of the thyroid gland. Eur Arch Otorhinolaryngol (2008) 0.87
Conservative management of well-differentiated thyroid cancer. Can J Surg (2010) 0.86
Recent advances in the surgical treatment of differentiated thyroid cancer: a comprehensive review. ScientificWorldJournal (2013) 0.85
Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab (2015) 0.85
The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher. Mol Imaging Radionucl Ther (2016) 0.83
Pathological characteristics and clinical perspectives of papillary thyroid cancer: study of 714 patients. Eur Arch Otorhinolaryngol (2013) 0.81
Controversies in the management of papillary thyroid cancer revisited. ISRN Oncol (2011) 0.81
Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts. World J Surg (2007) 0.79
Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography. Oncol Lett (2015) 0.79
Completion lobectomy and central compartment dissection in low-risk patients who had undergone less extensive surgery than hemithyroidectomy. Oncol Lett (2012) 0.78
Risk Factors Associated with Disease Recurrence among Patients with Low-Risk Papillary Thyroid Cancer Treated at the University of the Philippines-Philippine General Hospital. Endocrinol Metab (Seoul) (2016) 0.76
What is the Minimal Surgery for Papillary Thyroid Carcinoma? Rambam Maimonides Med J (2016) 0.76
A cross-specialty survey to assess the application of risk stratified surgery for differentiated thyroid cancer in the UK. Ann R Coll Surg Engl (2014) 0.75
Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins. PeerJ (2016) 0.75
Predictors of Regional Lymph Node Recurrence after Initial Thyroidectomy in Patients with Thyroid Cancer. J Thyroid Res (2016) 0.75
An unexpected finding in the resection specimen of a carcinoma of the oral cavity: A case report. Int J Surg Case Rep (2015) 0.75
Pediatric thyroid cancers: an Indian perspective. Indian J Surg Oncol (2012) 0.75
Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region. G Chir (2016) 0.75
Surgical decision making in the management of well-differentiated thyroid cancer. Indian J Surg Oncol (2012) 0.75
Risk-stratified management of well-differentiated thyroid cancers: a review of experience from a single institution, 1990-2003. World J Surg (2008) 0.75
Controversies in the Management of Low-Risk Differentiated Thyroid Cancer. Endocr Rev (2017) 0.75
Is There Justification for Total Thyroidectomy in Low-Risk Papillary Thyroid Carcinoma? A Decision-Analysis Model. World J Surg (2015) 0.75
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res (1999) 2.40
Prognostic significance of lymph node dissection in the treatment of malignant melanoma. Cancer (1970) 2.08
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol (2002) 1.96
Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery (1999) 1.94
Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck (1996) 1.82
Angiosarcoma of the head and neck. Am J Surg (1994) 1.78
Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg (1997) 1.71
Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg (1993) 1.69
Chondrosarcomas of the head and neck. World J Surg (1993) 1.65
Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab (2014) 1.65
Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg (1996) 1.65
Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res (2001) 1.62
Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol (1996) 1.61
Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg (1992) 1.48
Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol (2010) 1.46
Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer (1995) 1.45
Intermediate-risk group for differentiated carcinoma of thyroid. Surgery (1994) 1.42
Hypopharyngeal cancer patient care evaluation. Laryngoscope (1997) 1.42
Risk group-based management of differentiated thyroid carcinoma. J R Coll Surg Edinb (2001) 1.42
Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg (1999) 1.40
Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg (1995) 1.40
Complications of the pectoralis major myocutaneous flap in head and neck reconstruction. Am J Surg (1990) 1.39
Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum Pathol (1998) 1.38
Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol (2001) 1.37
Basaloid squamous cell carcinoma of the head and neck. Laryngoscope (2000) 1.36
Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg (1995) 1.36
Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head Neck (1998) 1.35
Hamartomas of the lung. Surg Gynecol Obstet (1973) 1.33
Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg (1972) 1.30
Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck (1990) 1.30
Critical assessment of supraomohyoid neck dissection. Am J Surg (1988) 1.27
Dermatofibrosarcoma protuberans of the head and neck. Ann Surg Oncol (2000) 1.25
Pitfalls of local excision in the treatment of carcinoma of the breast. Surg Gynecol Obstet (1973) 1.25
Craniofacial resection for anterior skull base tumors. Head Neck Surg (1989) 1.22
Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg (1990) 1.21
Benign solitary lung lesions in patients with cancer. Ann Surg (1978) 1.21
Complications of craniofacial resection for tumors involving the anterior skull base. Head Neck (1994) 1.20
Surgical grand rounds. Neck dissection: current status and future possibilities. Clin Bull (1981) 1.20
The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer (1992) 1.18
AJCC stage groupings for head and neck cancer: should we look at alternatives? A report of the Head and Neck Sites Task Force. Head Neck (2001) 1.15
The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg (1996) 1.14
Juvenile nasopharyngeal angiofibroma. A 30 year clinical review. Am J Surg (1983) 1.14
Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer (1999) 1.14
The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg (1979) 1.13
Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg (1984) 1.12
Quality of life of maxillectomy patients using an obturator prosthesis. Head Neck (1996) 1.12
Full thickness chest wall resection for recurrent breast carcinoma involving the bony chest wall. Cancer (1975) 1.12
Parathyroid carcinoma. Clin Oncol (R Coll Radiol) (2010) 1.11
Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma. Hum Gene Ther (2001) 1.10
Craniofacial resection for malignant tumors of ethmoid and anterior skull base. Arch Otolaryngol (1977) 1.08
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck (1997) 1.08
Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br J Cancer (2013) 1.06
Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg (1984) 1.06
Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. J Am Coll Surg (2001) 1.06
Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg (1984) 1.04
Craniofacial resection for malignant neoplasms of the skull base: an overview. J Surg Oncol (1998) 1.04
Desmoid tumors of the head and neck--a clinical study of a rare entity. Head Neck (2000) 1.04
Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg (1993) 1.04
Soft tissue sarcomas of the head and neck: an update. Am J Otolaryngol (2001) 1.04
Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery (1995) 1.04
Conservation surgery for radiation-failure carcinoma of the glottic larynx. Head Neck (1990) 1.03
Posterior triangle metastases of squamous cell carcinoma of the upper aerodigestive tract. Am J Surg (1993) 1.03
Locally invasive, well-differentiated thyroid cancer. 22 years' experience at Memorial Sloan-Kettering Cancer Center. Am J Surg (1981) 1.03
Primary adenocarcinoma of cervical esophagus. J Exp Clin Cancer Res (2005) 1.01
Mucosal melanomas of the head and neck. Am J Surg (1977) 1.01
Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland. Surgery (1993) 1.00
Carcinoma of the oral cavity. factors affecting treatment failure at the primary site and neck. Am J Surg (1976) 0.98
The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg (1994) 0.98
The Shaw Hemostatic Scalpel as an alternative to electrocautery in patients with pacemakers. Anesthesiology (1996) 0.98
Maxillectomy and its classification. Head Neck (1997) 0.97
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol (2001) 0.97
Diagnostic dilemma involving calcification in the parapharyngeal space: metastatic thyroid carcinoma masquerading as a deep lobe parotid mass. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 0.96
Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma. Am J Surg Pathol (1985) 0.96
Gastric transposition in head and neck surgery. Indications, complications, and expectations. Am J Surg (1983) 0.96
A clinicopathologic study of amelanotic melanoma. Surg Gynecol Obstet (1972) 0.96
Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg (1997) 0.95
Malignant melanoma in the North American Negro. Surg Gynecol Obstet (1971) 0.94
Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer. J Surg Oncol (1990) 0.94
Epidermoid carcinoma of the supraglottic larynx. Role of neck dissection in initial surgical treatment. Am J Surg (1974) 0.94
Resection and immediate microvascular reconstruction in the management of osteoradionecrosis of the mandible. Head Neck (1997) 0.93
Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg (1984) 0.93
Mandibulotomy approach to oropharyngeal tumors. Am J Surg (1985) 0.93
NCCN Practice Guidelines for Head and Neck Cancers. Oncology (Williston Park) (2000) 0.92
Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol (2014) 0.92
Epidermoid carcinoma of the palate. Am J Surg (1981) 0.91
Simultaneously presenting head and neck and lung cancer: a diagnostic and treatment dilemma. Laryngoscope (2002) 0.91
Patterns of failure in differentiated carcinoma of the thyroid based on risk groups. Head Neck (1998) 0.90
In vivo native cellular fluorescence and histological characteristics of head and neck cancer. Clin Cancer Res (1998) 0.90
Treatment of recurrent pleomorphic adenomas of the parotid gland. Otolaryngol Head Neck Surg (1999) 0.90
Major salivary gland lymphoepithelial lesions and the acquired immunodeficiency syndrome. Am J Surg (1991) 0.90